Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Pdl Biopharma Inc (PDLI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2015	12-2014	12-2013	12-2012	12-2011
Assets
Current Assets
Cash & Cash Equivalents	218,883	291,377	94,302	131,212	168,544
Marketable Securities	1,469	2,310	5,238	37,477	42,301
Receivables	N/A	300	300	366	600
Income taxes - deferred	981	375	377	1,613	10,054
Other current assets	58,398	57,597	1,208	7,504	0
TOTAL	$282,710	$355,897	$107,697	$182,985	$233,513

Non-Current Assets
PPE Net	31	62	41	59	22
Investments And Advances	0	0	0	0	17,101
Intangibles	399,204	259,244	235,677	0	0
Other Non-Current Assets	330,260	347,147	200,540	96,922	18,835
TOTAL	$729,495	$606,453	$436,258	$96,981	$35,958

Total Assets	$1,012,205	$962,350	$543,955	$279,966	$269,471

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	25,360	318	74,684	1,074	528
Accrued Expenses	N/A	N/A	N/A	N/A	120,870
TOTAL	$36,741	$187,983	$407,424	$10,474	$133,007

Non-Current Liabilities
Other Non-Current Liabilities	279,512	313,930	23,042	337,614	340,737
TOTAL	$279,512	$313,930	$23,042	$337,614	$340,737

Total Liabilities	$316,253	$501,913	$430,466	$348,088	$473,744

Shareholders' Equity
Shares Outstanding, K	164,287	162,751	160,352	139,983	139,875
Common Shares	1,643	1,622	1,399	1,398	1,397
Retained earnings	810,036	575,740	350,151	169,634	-42,035
Other shareholders' equity	2,256	2,949	-4,888	-5,088	-1,885
TOTAL	$695,952	$460,437	$113,489	$-68,122	$-204,273

Total Liabilities And Equity	$1,012,205	$962,350	$543,955	$279,966	$269,471